Residents

Appili Therapeutics

Appili Therapeutics

Appili Therapeutics is dedicated to identifying, acquiring and advancing novel therapeutics in the area of infectious disease. Appili has commenced development on two antibiotic programs, ATI-1501 and ATI-1503, while continuing our search for additional high quality anti-infective programs suitable for acquisition. 

Area of focus: 
Infectious Diseases & Vaccines
Commencement date: 
01/16/2017

Share